Biogen's Alzheimer's Drug Poses a Dilemma for the F.D.A.


If the agency approves it, aducanumab would be the first new Alzheimer's treatment since 2003. Patients are desperate for new options, but some scientists say ... Read more

Bron: NYT > Home Page
Tags:
Geplaatst: 06 Jun 2021 - 13:56